You are invited to hear about the recent renascence in the research of psilocybin for the treatment of major depression disorder and other behavior problems.
CALPACS is excited to invite Dr. Robert Kargbo from the Usona Institute to share their journey from chemical synthesis to the recent Phase II clinical trial program with psilocybin. Dr. Kargbo has been instrumental in advancing this field through the optimization of the chemical synthesis of psilocybin and other psychedelic compounds. These discoveries enabled the large-scale manufacturing and formulation of active pharmaceutical ingredients to be fed into the clinical trials. Further, hear his experience, insight, and progression of other psychedelic drugs and their treatment for a variety of societal maladies.
Continue reading “CALPACS Sponsored Lecture on Psilocybin”